Menu
English
Stock Code: 00512.HK

Information Disclosure

Home
Information Disclosure

Contact Us

Units 3302, 33/F, The Center, 99 Queen's Road Central, Hong Kong

ir@chinagrandpharm.com

www.chinagrandpharm.com

Pages Links

Company Profile

Investor Relations

Legal Statement

Recent News

Four Products of GP (HK) that Obtained Consistency Evaluation Approvals, Namely Sodium Bicarbonate Tablets, Trimetazidine Tablets, Finasteride Tablets and Captopril Tablets, Have Successfully Won the Bids in the Third Batch of National Centralized Drug Procurement

2020-8-20
GP (HK) Announces 2020 Interim Results Profit Attributable to Owners of the Company Rapidly Increases 31.4% to HK$718.5 million With A Focus on Global Expansion and Self-Development Seven Investment, M&A and Cooperation Projects Progress Steadily

2020-8-10

© 2020. China Grand Pharmaceutical and Healthcare Holdings Limited All Rights Reserved.